{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:26:49Z","timestamp":1781951209415,"version":"3.54.5"},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.neurol.2025.01.003","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T12:49:25Z","timestamp":1737982165000},"page":"235-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ureaplasma urealyticum septic hip arthritis associated with ocrelizumab therapy in a young patient with multiple sclerosis"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4141-3512","authenticated-orcid":false,"given":"J.","family":"Le Bars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hervouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-2266","authenticated-orcid":false,"given":"E.","family":"Le Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2025.01.003_bib0035","doi-asserted-by":"crossref","first-page":"578066","DOI":"10.1016\/j.jneuroim.2023.578066","article-title":"Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD","volume":"377","author":"Mears","year":"2023","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.neurol.2025.01.003_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5194\/jbji-9-167-2024","article-title":"Ureaplasma urealyticum osteomyelitis of the greater trochanter in a patient with multiple sclerosis using ocrelizumab \u2013 a case report","volume":"9","author":"Ruythooren","year":"2024","journal-title":"J Bone Jt Infect"},{"issue":"9","key":"10.1016\/j.neurol.2025.01.003_bib0045","doi-asserted-by":"crossref","first-page":"e256029","DOI":"10.1136\/bcr-2023-256029","article-title":"Severe Ureaplasma urealyticum infection in a patient with ocrelizumab-induced hypogammaglobulinaemia","volume":"16","author":"Poulsen","year":"2023","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.neurol.2025.01.003_bib0050","doi-asserted-by":"crossref","first-page":"e01744","DOI":"10.1016\/j.idcr.2023.e01744","article-title":"Native joint polyarticular septic arthritis secondary to disseminated Ureaplasma urealyticum infection in a patient on rituximab therapy with hypogammaglobulinemia: a case report","volume":"32","author":"El Zein","year":"2023","journal-title":"IDCases"},{"issue":"3","key":"10.1016\/j.neurol.2025.01.003_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/ard.53.3.183","article-title":"Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: microbiological observations over twenty years","volume":"53","author":"Furr","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.neurol.2025.01.003_bib0060","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.medj.2023.05.001","article-title":"Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis","volume":"4","author":"Schuckmann","year":"2023","journal-title":"Medicine"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T19:47:05Z","timestamp":1742240825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0035378725000190"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.01.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ureaplasma urealyticum septic hip arthritis associated with ocrelizumab therapy in a young patient with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}